Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin
- 1 May 1992
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 19 (5), 322-329
- https://doi.org/10.1007/bf00177053
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1991
- Monoclonal antibody pretargetting techniques for tumour localizationNuclear Medicine Communications, 1991
- Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111Bioconjugate Chemistry, 1990
- In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: A strategy to increase tumor radiolocalizationInternational Journal of Cancer, 1988
- Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenograftsInternational Journal of Cancer, 1988
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987
- Cancer Statistics, 1987CA: A Cancer Journal for Clinicians, 1987
- Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab′)2 fragments of an anti-melanoma monoclonal antibodyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983